These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
☒
|
Accelerated Filer
|
☐
|
|
Non-accelerated Filer
|
☐
|
Smaller reporting Company
|
|
|
|
|
Emerging growth company
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
PART I. FINANCIAL INFORMATION
|
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
(Unaudited)
|
|
|
||||
|
ASSETS
|
|
|
|
||||
|
Investments:
|
|
|
|
||||
|
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2020 - $22,836; December 31, 2019 - $22,914 and allowance for expected credit losses: March 31, 2020 - $44; December 31, 2019 - $0)
|
$
|
|
|
|
$
|
|
|
|
Equity securities, at fair value (cost: March 31, 2020 - $1,052; December 31, 2019 - $1,069)
|
|
|
|
|
|
||
|
Derivative investments, at fair value
|
|
|
|
|
|
||
|
Mortgage loans (allowance for expected credit losses: March 31, 2020 - $12; December 31, 2019 - $0)
|
|
|
|
|
|
||
|
Other invested assets
|
|
|
|
|
|
||
|
Total investments
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
|
|
|
|
|
||
|
Accrued investment income
|
|
|
|
|
|
||
|
Funds withheld for reinsurance receivables, at fair value
|
|
|
|
|
|
||
|
Reinsurance recoverable (allowance for expected credit losses: March 31, 2020 - $22; December 31, 2019 - $0)
|
|
|
|
|
|
||
|
Intangibles, net
|
|
|
|
|
|
||
|
Deferred tax assets, net
|
|
|
|
|
|
||
|
Goodwill
|
|
|
|
|
|
||
|
Other assets
|
|
|
|
|
|
||
|
Total assets
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
|
|
|
||||
|
|
|
|
|
||||
|
Contractholder funds
|
$
|
|
|
|
$
|
|
|
|
Future policy benefits, including $1,904 and $1,953 at fair value at March 31, 2020 and December 31, 2019, respectively
|
|
|
|
|
|
||
|
Funds withheld for reinsurance liabilities
|
|
|
|
|
|
||
|
Liability for policy and contract claims
|
|
|
|
|
|
||
|
Debt
|
|
|
|
|
|
||
|
Other liabilities
|
|
|
|
|
|
||
|
Total liabilities
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Commitments and contingencies ("Note 12")
|
|
|
|
||||
|
|
|
|
|
||||
|
Shareholders' equity:
|
|
|
|
||||
|
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 437,841 and 429,789 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively)
|
|
|
|
|
|
||
|
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,972,605 and 221,807,598 issued and outstanding at March 31, 2020 and December 31, 2019, respectively
|
|
|
|
|
|
||
|
Additional paid-in capital
|
|
|
|
|
|
||
|
Retained earnings (Accumulated deficit)
|
(
|
)
|
|
|
|
||
|
Accumulated other comprehensive income (loss)
|
(
|
)
|
|
|
|
||
|
Treasury stock, at cost (8,652,400 shares at March 31, 2020 and December 31, 2019)
|
(
|
)
|
|
(
|
)
|
||
|
Total shareholders' equity
|
|
|
|
|
|
||
|
Total liabilities and shareholders' equity
|
$
|
|
|
|
$
|
36,714
|
|
|
|
|
|
|
||||
|
|
|||||||
|
|
Three months ended
|
||||||
|
|
March 31,
2020 |
|
March 31,
2019 |
||||
|
|
(Unaudited)
|
|
(Unaudited)
|
||||
|
Revenues:
|
|
|
|
||||
|
Premiums
|
$
|
|
|
|
$
|
|
|
|
Net investment income
|
|
|
|
|
|
||
|
Net investment gains (losses)
|
(
|
)
|
|
|
|
||
|
Insurance and investment product fees and other
|
|
|
|
|
|
||
|
Total revenues
|
(
|
)
|
|
|
|
||
|
Benefits and expenses:
|
|
|
|
||||
|
Benefits and other changes in policy reserves
|
(
|
)
|
|
|
|
||
|
Acquisition and operating expenses, net of deferrals
|
|
|
|
|
|
||
|
Amortization of intangibles
|
(
|
)
|
|
|
|
||
|
Total benefits and expenses
|
(
|
)
|
|
|
|
||
|
Operating income (loss)
|
(
|
)
|
|
|
|
||
|
Interest expense
|
(
|
)
|
|
(
|
)
|
||
|
Income (loss) before income taxes
|
(
|
)
|
|
|
|
||
|
Income tax (expense) benefit
|
(
|
)
|
|
(
|
)
|
||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
Less Preferred stock dividend
|
|
|
|
|
|
||
|
Net income (loss) available to common shareholders
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
||||
|
Net income (loss) per common share:
|
|
|
|
||||
|
Basic
|
$
|
(
|
)
|
|
$
|
|
|
|
Diluted
|
$
|
(
|
)
|
|
$
|
|
|
|
Weighted average common shares used in computing net income (loss) per common share:
|
|
|
|
||||
|
Basic
|
|
|
|
|
|
||
|
Diluted
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Cash dividend per common share
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
Supplemental disclosures
|
|
|
|
||||
|
Total other-than-temporary impairments
|
$
|
|
|
|
$
|
(
|
)
|
|
Gains (losses) on derivatives and embedded derivatives
|
(
|
)
|
|
|
|
||
|
Other investment gains (losses)
|
(
|
)
|
|
|
|
||
|
Change in allowance for expected credit losses
|
(48
|
)
|
|
—
|
|
||
|
Total net investment gains (losses)
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Three months ended
|
||||||
|
|
March 31,
2020 |
|
March 31,
2019 |
||||
|
|
(Unaudited)
|
|
(Unaudited)
|
||||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
||||
|
Other comprehensive income (loss):
|
|
|
|
||||
|
Change in unrealized gains/losses on investments, net of adjustments to intangible assets and unearned revenue
|
(
|
)
|
|
|
|
||
|
Changes in deferred income tax asset/liability
|
200
|
|
|
(55
|
)
|
||
|
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk
|
|
|
|
(
|
)
|
||
|
|
|
|
|
||||
|
Net changes to derive comprehensive income (loss) for the period
|
(
|
)
|
|
|
|
||
|
Comprehensive income (loss), net of tax
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Retained Earnings (Accumulated Deficit)
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Treasury Stock
|
|
Total Shareholders' Equity
|
||||||||||||||
|
Balance, December 31, 2019
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Preferred stock (paid in kind)
|
|
—
|
|
|
—
|
|
|
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Common stock ($0.01/share)
|
|
—
|
|
|
—
|
|
|
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||||
|
Net income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|||||||
|
Unrealized investment gains (losses), net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
(
|
)
|
|||||||
|
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|||||||
|
Cumulative effect of changes in accounting principles
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(24
|
)
|
|
—
|
|
|
—
|
|
|
(24
|
)
|
|||||||
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Balance, March 31, 2020
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional Paid-in Capital
|
|
Retained Earnings (Accumulated Deficit)
|
|
Accumulated Other Comprehensive Income (Loss)
|
|
Treasury Stock
|
|
Total Shareholders' Equity
|
||||||||||||||
|
Balance, December 31, 2018
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Dividends
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Preferred stock (paid in kind)
|
|
—
|
|
|
—
|
|
|
|
|
|
(
|
)
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Common stock ($0.01/share)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|||||||
|
Net income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
|
|
|||||||
|
Unrealized investment gains (losses), net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
—
|
|
|
|
|
|||||||
|
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(
|
)
|
|
—
|
|
|
(
|
)
|
|||||||
|
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||||
|
Balance, March 31, 2019
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Three months ended
|
||||||
|
|
March 31,
2020 |
|
March 31,
2019 |
||||
|
|
(Unaudited)
|
|
(Unaudited)
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
|
|
|
||||
|
Stock based compensation
|
|
|
|
|
|
||
|
Amortization
|
|
|
|
|
|
||
|
Deferred income taxes
|
|
|
|
|
|
||
|
Interest credited/index credits to contractholder account balances
|
|
|
|
|
|
||
|
Net recognized (gains) losses on investments and derivatives
|
|
|
|
(
|
)
|
||
|
Charges assessed to contractholders for mortality and administration
|
(
|
)
|
|
(
|
)
|
||
|
Intangibles, net
|
(
|
)
|
|
(
|
)
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Reinsurance recoverable
|
(
|
)
|
|
(
|
)
|
||
|
Future policy benefits reflected in net income (loss)
|
(
|
)
|
|
|
|
||
|
Funds withheld for reinsurers
|
(
|
)
|
|
(
|
)
|
||
|
Collateral (returned) posted
|
(
|
)
|
|
|
|
||
|
Other assets and other liabilities
|
|
|
|
(
|
)
|
||
|
Net cash provided by (used in) operating activities
|
(
|
)
|
|
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Proceeds from fixed maturity securities, available-for-sale investments sold, matured or repaid
|
|
|
|
|
|
||
|
Proceeds from derivatives instruments and other invested assets
|
|
|
|
|
|
||
|
Proceeds from mortgage loans
|
|
|
|
|
|
||
|
Costs of fixed matuirty securities, available-for-sale investments
|
(
|
)
|
|
(
|
)
|
||
|
Costs of derivatives instruments and other invested assets
|
(
|
)
|
|
(
|
)
|
||
|
Costs of mortgage loans
|
(
|
)
|
|
(
|
)
|
||
|
Capital expenditures
|
(
|
)
|
|
(
|
)
|
||
|
Net cash provided by (used in) investing activities
|
(
|
)
|
|
|
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Treasury stock
|
|
|
|
(
|
)
|
||
|
Common stock dividends paid
|
(
|
)
|
|
(
|
)
|
||
|
Contractholder account deposits
|
|
|
|
|
|
||
|
Contractholder account withdrawals
|
(
|
)
|
|
(
|
)
|
||
|
Net cash provided by (used in) financing activities
|
|
|
|
|
|
||
|
Change in cash and cash equivalents
|
(
|
)
|
|
|
|
||
|
Cash and cash equivalents, beginning of period
|
|
|
|
|
|
||
|
Cash and cash equivalents, end of period
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
|
Income taxes (refunded) paid
|
$
|
|
|
|
$
|
(
|
)
|
|
Deferred sales inducements
|
$
|
|
|
|
$
|
|
|
|
•
|
the subsequent measurement of goodwill is simplified by the elimination of step 2 from the goodwill impairment test, which required an entity to determine the implied fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination
|
|
•
|
the entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, not to exceed the total amount of goodwill allocated to that reporting unit
|
|
•
|
the entity is no longer required to perform a qualitative assessment for any reporting unit with a zero or negative carrying amount
|
|
•
|
for investments in certain entities that calculate net asset value, investors are required to disclose the timing of liquidation of an investee's assets and the date when restrictions from redemption might lapse if the investee has communicated timing to the entity or announced timing publicly
|
|
•
|
entities should use the measurement uncertainty disclosure to communicate information about the uncertainty in measurement as of the reporting date
|
|
•
|
entities must disclose changes in unrealized gains and losses included in other comprehensive income for recurring Level 3 fair value measurements, as well as the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, or other quantitative information in lieu of weighted average if the entity determines such information would be more reasonable and rational
|
|
•
|
entities are no longer required to disclose the amounts and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements
|
|
•
|
financial assets (or a group of financial assets) measured at amortized cost are required to be presented at the net amount expected to be collected, with an allowance for expected credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount
|
|
•
|
credit losses relating to available-for-sale ("AFS") fixed maturity securities generally are recorded through an allowance for expected credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for expected credit losses for AFS fixed maturity securities is limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value
|
|
•
|
the income statement reflects the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount
|
|
•
|
assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations
|
|
•
|
the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income
|
|
•
|
market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income
|
|
•
|
deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts
|
|
•
|
deferred acquisition costs must be written off for unexpected contract terminations
|
|
•
|
disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition
|
|
•
|
accounting for income taxes is simplified by removing certain exceptions, including exceptions related to the incremental approach for intraperiod tax allocation, calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences
|
|
•
|
the accounting for franchise taxes, transactions that result in a step-up in the tax basis of goodwill and enacted changes in tax laws or rates has been clarified
|
|
•
|
the consolidated amount of current and deferred tax expense to a legal entity that is not subject to tax in its separate financial statements is not required to be allocated, although the entity may elect to do so
|
|
|
March 31, 2020
|
||||||||||||||||||||||
|
|
Amortized Cost
|
|
Allowance for Expected Credit Losses
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Carrying Value
|
||||||||||||
|
Available-for-sale securities
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Asset-backed securities
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Corporates
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Hybrids
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Municipals
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Residential mortgage-backed securities
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
U.S. Government
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Foreign Governments
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Total available-for-sale securities
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Equity securities
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Derivative investments
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||
|
Commercial mortgage loans
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Residential mortgage loans
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Other invested assets
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||||
|
Total investments
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
|
December 31, 2019
|
||||||||||||||||||
|
|
Amortized Cost
|
|
Gross Unrealized Gains
|
|
Gross Unrealized Losses
|
|
Fair Value
|
|
Carrying Value
|
||||||||||
|
Available-for-sale securities
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Asset-backed securities
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Corporates
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Hybrids
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Municipals
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
U.S. Government
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Foreign Governments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total available-for-sale securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Equity securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Derivative investments
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Commercial mortgage loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Residential mortgage loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Other invested assets
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||
|
Total investments
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
|
March 31, 2020
|
||||||
|
|
Amortized Cost
|
|
Fair Value
|
||||
|
Corporates, Non-structured Hybrids, Municipal and Government securities:
|
|
|
|
||||
|
Due in one year or less
|
$
|
|
|
|
$
|
|
|
|
Due after one year through five years
|
|
|
|
|
|
||
|
Due after five years through ten years
|
|
|
|
|
|
||
|
Due after ten years
|
|
|
|
|
|
||
|
Subtotal
|
|
|
|
|
|
||
|
Other securities which provide for periodic payments:
|
|
|
|
||||
|
Asset-backed securities
|
|
|
|
|
|
||
|
Commercial mortgage-backed securities
|
|
|
|
|
|
||
|
Residential mortgage-backed securities
|
|
|
|
|
|
||
|
Subtotal
|
|
|
|
|
|
||
|
Total fixed maturity available-for-sale securities
|
$
|
|
|
|
$
|
|
|
|
•
|
The extent to which the fair value is less than the amortized cost basis;
|
|
•
|
The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening);
|
|
•
|
The financial condition of and near-term prospects of the issuer (including issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength);
|
|
•
|
Current delinquencies and nonperforming assets of underlying collateral;
|
|
•
|
Expected future default rates;
|
|
•
|
Collateral value by vintage, geographic region, industry concentration or property type;
|
|
•
|
Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and
|
|
•
|
Contractual and regulatory cash obligations and the issuer's plans to meet such obligations.
|
|
•
|
The Company believes amounts related to securities have become uncollectible; or
|
|
•
|
The Company intends to sell a security; or
|
|
•
|
It is more likely than not that the Company will be required to sell a security prior to recovery.
|
|
|
For the quarter ended March 31, 2020
|
||||||||||||||||||||||||||
|
|
|
Additions
|
|
Reductions
|
|
|
|||||||||||||||||||||
|
|
Balance at Beginning of Period
|
For credit losses on securities for which losses were not previously recorded
|
For initial credit losses on purchased securities accounted for as PCD financial assets (a)
|
Additions (reductions) in allowance recorded on previously impaired securities
|
|
For securities sold during the period
|
For securities intended/required to be sold prior to recovery of amortized cost basis
|
|
Writeoffs charged against the allowance
|
|
Balance at End of Period
|
||||||||||||||||
|
Available-for-sale securities
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Asset-backed securities
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
(
|
)
|
||||||||
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
||||||||
|
Corporates
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
(
|
)
|
||||||||
|
Hybrids
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
||||||||
|
Municipals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
||||||||
|
Residential mortgage-backed securities
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
(
|
)
|
||||||||
|
US Government
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
||||||||
|
Foreign Government
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|
|
|
||||||||
|
Total available-for-sale securities
|
$
|
|
|
$
|
(
|
)
|
$
|
|
|
$
|
|
|
|
$
|
|
|
$
|
|
|
|
$
|
1
|
|
|
$
|
(
|
)
|
|
|
March 31, 2020
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
|
|
Fair Value
|
|
Gross Unrealized
Losses
|
|
Fair Value
|
|
Gross Unrealized
Losses
|
|
Fair Value
|
|
Gross Unrealized
Losses
|
||||||||||||
|
Available-for-sale securities
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Asset-backed securities
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
Commercial mortgage-backed securities
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Corporates
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Hybrids
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Municipals
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Residential mortgage-backed securities
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Foreign Government
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
||||||
|
Total available-for-sale securities
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
Total number of available-for-sale securities in an unrealized loss position less than twelve months
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total number of available-for-sale securities in an unrealized loss position twelve months or longer
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total number of available-for-sale securities in an unrealized loss position
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
December 31, 2019
|
||||||||||||||||||||||
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
|
|
Fair Value
|
|
Gross Unrealized
Losses
|
|
Fair Value
|
|
Gross Unrealized
Losses
|
|
Fair Value
|
|
Gross Unrealized
Losses
|
||||||||||||
|
Available-for-sale securities
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Asset-backed securities
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
Commercial mortgage-backed securities
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Corporates
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Hybrids
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Municipals
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||
|
U.S. Government
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Total available-for-sale securities
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
Total number of available-for-sale securities in an unrealized loss position less than twelve months
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total number of available-for-sale securities in an unrealized loss position twelve months or longer
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
Total number of available-for-sale securities in an unrealized loss position
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
Three months ended
|
|||
|
|
|
March 31, 2019
|
||
|
Credit impairment losses in operations
|
|
$
|
(
|
)
|
|
Change-of-intent losses in operations
|
|
|
|
|
|
Amortized cost
|
|
|
|
|
|
Fair value
|
|
|
|
|
|
Non-credit losses in other comprehensive income for investments which experienced OTTI
|
|
|
|
|
|
|
Three months ended
|
|||
|
|
|
March 31, 2019
|
||
|
Corporates
|
|
$
|
(
|
)
|
|
Total
|
|
$
|
(
|
)
|
|
|
|
Three months ended
|
||
|
|
|
March 31, 2019
|
||
|
Beginning balance
|
|
$
|
|
|
|
Increases attributable to credit losses on securities:
|
|
|
||
|
OTTI was previously recognized
|
|
|
|
|
|
OTTI was not previously recognized
|
|
|
|
|
|
Ending balance
|
|
$
|
|
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||
|
|
Gross Carrying Value
|
|
% of Total
|
|
Gross Carrying Value
|
|
% of Total
|
||||||
|
Property Type:
|
|
|
|
|
|
|
|
||||||
|
Hotel
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
Industrial - General
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Industrial - Warehouse
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Multifamily
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Office
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Retail
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Total commercial mortgage loans, gross of valuation allowance
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
Allowance for expected credit loss
|
(
|
)
|
|
|
|
|
|
|
|
||||
|
Total commercial mortgage loans
|
$
|
|
|
|
|
|
$
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||||||
|
U.S. Region:
|
|
|
|
|
|
|
|
||||||
|
East North Central
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
East South Central
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Middle Atlantic
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Mountain
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
New England
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Pacific
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
South Atlantic
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
West North Central
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
West South Central
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Total commercial mortgage loans, gross of valuation allowance
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
Allowance for expected credit loss
|
(
|
)
|
|
|
|
|
|
|
|
||||
|
Total commercial mortgage loans
|
$
|
|
|
|
|
|
$
|
|
|
|
|
||
|
|
Debt-Service Coverage Ratios
|
|
Total Amount
|
|
% of Total
|
|
Estimated Fair Value
|
|
% of Total
|
||||||||||||
|
|
>1.25
|
|
1.00 - 1.25
|
|
|
|
|
||||||||||||||
|
March 31, 2020
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
LTV Ratios:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Less than 50%
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
50% to 60%
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||||
|
60% to 75%
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||||
|
Commercial mortgage loans
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
December 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
LTV Ratios:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Less than 50%
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
50% to 60%
|
|
|
|
|
|
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||||
|
Commercial mortgage loans
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
|
March 31, 2020
|
|||||
|
US State:
|
Unpaid Principal Balance
|
|
% of Total
|
|||
|
California
|
$
|
|
|
|
|
%
|
|
Florida
|
|
|
|
|
%
|
|
|
New Jersey
|
|
|
|
|
%
|
|
|
All Other States (a)
|
|
|
|
|
%
|
|
|
Total mortgage loans
|
$
|
|
|
|
|
%
|
|
|
December 31, 2019
|
|||||
|
US State:
|
Unpaid Principal Balance
|
|
% of Total
|
|||
|
California
|
$
|
|
|
|
|
%
|
|
Florida
|
|
|
|
|
%
|
|
|
New Jersey
|
|
|
|
|
%
|
|
|
All Other States (a)
|
|
|
|
|
%
|
|
|
Total mortgage loans
|
$
|
|
|
|
|
%
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||
|
Performance indicators:
|
Carrying Value
|
|
% of Total
|
|
Carrying Value
|
|
% of Total
|
||||||
|
Performing
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
Non-performing
|
|
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Total residential mortgage loans, gross of valuation allowance
|
$
|
|
|
|
|
%
|
|
|
|
|
|
%
|
|
|
Allowance for expected credit loss
|
(
|
)
|
|
|
%
|
|
|
|
|
|
%
|
||
|
Total residential mortgage loans
|
$
|
|
|
|
|
%
|
|
$
|
|
|
|
|
%
|
|
|
March 31, 2020
|
|||||||||||||
|
|
Term Loans
|
|||||||||||||
|
|
Amortized Cost by Origination Year
|
|||||||||||||
|
|
2020
|
2019
|
2018
|
2017
|
2016
|
Prior
|
Total
|
|||||||
|
Residential mortgages
|
|
|
|
|
|
|
|
|||||||
|
Current (less than 30 days past due)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-89 days past due
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Over 90 days past due
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total residential mortgages
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgages
|
|
|
|
|
|
|
|
|||||||
|
Current (less than 30 days past due)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-89 days past due
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Over 90 days past due
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total commercial mortgage
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2020
|
|||||||||||||
|
|
Term Loans
|
|||||||||||||
|
|
Amortized Cost by Origination Year
|
|||||||||||||
|
|
2020
|
2019
|
2018
|
2017
|
2016
|
Prior
|
Total
|
|||||||
|
Commercial mortgages
|
|
|
|
|
|
|
|
|||||||
|
LTV
|
|
|
|
|
|
|
|
|||||||
|
Less than 50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50% to 60%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60% to 75%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total commercial mortgages
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial mortgages
|
|
|
|
|
|
|
|
|||||||
|
DSCR
|
|
|
|
|
|
|
|
|||||||
|
Greater than 1.25x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.00x - 1.25x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less than 1.00x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total commercial mortgages
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage Loans
|
|
Commercial Mortgage Loans
|
|
Total
|
|||
|
Balance as at January 1, 2020
|
|
|
|
|
|
|
|
|
|
(Reversal of) provision for loan losses
|
|
|
|
|
|
|
|
|
|
Balance as at March 31, 2020
|
|
|
|
|
|
|
|
|
|
|
March 31, 2020
|
|
|
Residential Mortgage Loans
|
|
|
|
Commercial Mortgage Loans
|
|
|
|
Total loans that are 90 days or more past due and still accruing
|
|
|
|
|
Three months ended
|
||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
||||
|
Fixed maturity securities, available-for-sale
|
$
|
|
|
|
$
|
|
|
|
Equity securities
|
|
|
|
|
|
||
|
Mortgage loans
|
|
|
|
|
|
||
|
Invested cash and short-term investments
|
|
|
|
|
|
||
|
Funds withheld
|
|
|
|
|
|
||
|
Limited partnerships
|
|
|
|
|
|
||
|
Other investments
|
|
|
|
|
|
||
|
Gross investment income
|
|
|
|
|
|
||
|
Investment expense
|
(
|
)
|
|
(
|
)
|
||
|
Net investment income
|
$
|
|
|
|
$
|
|
|
|
|
Three months ended
|
||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
||||
|
Net realized gains (losses) on fixed maturity available-for-sale securities
|
$
|
|
|
|
$
|
(
|
)
|
|
Net realized/unrealized gains (losses) on equity securities
|
(
|
)
|
|
|
|
||
|
Realized gains (losses) on other invested assets
|
(
|
)
|
|
|
|
||
|
Change in allowance for expected credit losses
|
(
|
)
|
|
|
|
||
|
Derivatives, embedded derivatives and financial instruments under fair value option:
|
|
|
|
||||
|
Realized gains (losses) on certain derivative instruments
|
|
|
|
(
|
)
|
||
|
Unrealized gains (losses) on certain derivative instruments
|
(
|
)
|
|
|
|
||
|
Change in fair value of reinsurance related embedded derivatives and change in fair value of funds withheld for reinsurance receivables, held at fair value (a)
|
(
|
)
|
|
(
|
)
|
||
|
Change in fair value of other derivatives and embedded derivatives
|
(
|
)
|
|
|
|
||
|
Realized gains (losses) on derivatives and embedded derivatives
|
(
|
)
|
|
|
|
||
|
Net investment gains (losses)
|
$
|
(
|
)
|
|
$
|
|
|
|
|
Three months ended
|
||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
||||
|
Proceeds
|
$
|
|
|
|
$
|
|
|
|
Gross gains
|
|
|
|
|
|
||
|
Gross losses
|
(
|
)
|
|
(
|
)
|
||
|
|
March 31, 2020
|
|
December 31, 2019
|
||||
|
Assets:
|
|
|
|
||||
|
Derivative investments:
|
|
|
|
||||
|
Call options
|
$
|
|
|
|
$
|
|
|
|
Other Invested Assets:
|
|
|
|
||||
|
Other embedded derivatives
|
|
|
|
|
|
||
|
Funds withheld:
|
|
|
|
||||
|
Call options
|
1
|
|
|
3
|
|
||
|
|
$
|
|
|
|
$
|
|
|
|
Liabilities:
|
|
|
|
||||
|
Contractholder funds:
|
|
|
|
||||
|
FIA embedded derivative
|
$
|
|
|
|
$
|
|
|
|
Other liabilities:
|
|
|
|
||||
|
Futures contracts
|
2
|
|
|
—
|
|
||
|
Reinsurance related embedded derivative
|
(18
|
)
|
|
33
|
|
||
|
Preferred shares reimbursement feature embedded derivative
|
|
|
|
|
|
||
|
|
$
|
|
|
|
$
|
|
|
|
|
Three months ended
|
||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
||||
|
Net investment gains (losses):
|
|
|
|
||||
|
Call options
|
$
|
(
|
)
|
|
$
|
|
|
|
Futures contracts
|
|
|
|
|
|
||
|
Foreign currency forward
|
|
|
|
|
|
||
|
Other derivatives and embedded derivatives
|
(
|
)
|
|
|
|
||
|
Reinsurance related embedded derivatives
|
(
|
)
|
|
(
|
)
|
||
|
Total net investment gains (losses)
|
$
|
(
|
)
|
|
$
|
|
|
|
|
|
|
|
||||
|
Benefits and other changes in policy reserves:
|
|
|
|
||||
|
FIA embedded derivatives
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
||||
|
Acquisition and operating expenses, net of deferrals:
|
|
|
|
||||
|
Preferred shares reimbursement feature embedded derivative
|
$
|
|
|
|
$
|
(
|
)
|
|
|
|
|
March 31, 2020
|
||||||||||||||
|
Counterparty
|
Credit Rating
(Fitch/Moody's/S&P) (a)
|
|
Notional
Amount |
|
Fair Value
|
|
Collateral
|
|
Net Credit Risk
|
||||||||
|
Merrill Lynch
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Deutsche Bank
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Morgan Stanley
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Barclay's Bank
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Canadian Imperial Bank of Commerce
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Wells Fargo
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Goldman Sachs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
December 31, 2019
|
||||||||||||||
|
Counterparty
|
Credit Rating
(Fitch/Moody's/S&P) (a) |
|
Notional
Amount |
|
Fair Value
|
|
Collateral
|
|
Net Credit Risk
|
||||||||
|
Merrill Lynch
|
A+/*/A+
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Deutsche Bank
|
BBB/A3/BBB+
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Morgan Stanley
|
*/A1/A+
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Barclay's Bank
|
A+/A2/A
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Canadian Imperial Bank of Commerce
|
*/Aa2/A+
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Wells Fargo
|
A+/A2/A-
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Goldman Sachs
|
A/A3/BBB+
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
March 31, 2020
|
||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
|
Carrying Amount
|
||||||||||
|
Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Asset-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Corporates
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Hybrids
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Municipals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
U.S. Government
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Foreign Governments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Equity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Derivative investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Other invested assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Funds withheld for reinsurance receivables, at fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total financial assets at fair value
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fair value of future policy benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Derivatives:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
FIA embedded derivatives, included in contractholder funds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Reinsurance related embedded derivative, included in other liabilities
|
|
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||
|
Derivative instruments - futures contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Preferred shares reimbursement feature embedded derivative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total financial liabilities at fair value
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
December 31, 2019
|
||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Fair Value
|
|
Carrying Amount
|
||||||||||
|
Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and cash equivalents
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Fixed maturity securities, available-for-sale:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Asset-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Corporates
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Hybrids
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Municipals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
U.S. Government
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Foreign Governments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Equity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Derivative investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Other invested assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Funds withheld for reinsurance receivables, at fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total financial assets at fair value
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Fair value of future policy benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Derivatives:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
FIA embedded derivatives, included in contractholder funds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Reinsurance related embedded derivative, included in other liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Preferred shares reimbursement feature embedded derivative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total financial liabilities at fair value
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Fair Value at
|
|
Valuation Technique
|
|
Unobservable Input(s)
|
|
Range (Weighted average)
|
||
|
|
March 31, 2020
|
|
|
|
March 31, 2020
|
||||
|
Assets
|
|
|
|
|
|
|
|
||
|
Asset-backed securities
|
$
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
91.53% - 112.18%
(97.88%) |
|
Asset-backed securities
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
0.00% - 105.02%
(71.27%) |
|
|
Commercial mortgage-backed securities
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
84.49% - 119.30%
(118.31%) |
|
|
Corporates
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
82.38% - 102.13%
(95.47%) |
|
|
Corporates
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
59.84% - 116.89%
(99.21%) |
|
|
Hybrids
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
100.80% - 100.80%
(100.80%) |
|
|
Municipals
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
118.01% - 118.01%
(118.01%) |
|
|
Residential mortgage-backed securities
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
0.00% - 103.20%
(103.20%) |
|
|
Residential mortgage-backed securities
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
95.61% - 95.61%
(95.61%) |
|
|
Foreign governments
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
102.02% - 102.85%
(102.28%) |
|
|
Equity securities (Salus preferred equity)
|
|
|
|
Income-Approach
|
|
Yield
|
|
2.33%
|
|
|
Other Invested Assets:
|
|
|
|
|
|
|
|
||
|
Available-for-sale embedded derivative (AnchorPath)
|
|
|
|
Black Scholes model
|
|
Market value of AnchorPath fund
|
|
100.00%
|
|
|
Credit Linked Note
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
100.00%
|
|
|
Total financial assets at fair value
|
$
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
||
|
Future policy benefits
|
|
|
|
Discounted cash flow
|
|
Market value of option
|
|
0.00% - 5.37%
(1.13%) |
|
|
|
|
|
|
|
Mortality multiplier
|
|
80.00% - 120.00%
(95.82%) |
||
|
|
|
|
|
|
Surrender rates
|
|
0.50% - 55.00%
(21.06%) |
||
|
|
|
|
|
|
Partial withdrawals
|
|
0.00% - 4.00%
(2.15%) |
||
|
|
|
|
|
|
Non-performance spread
|
|
0.00% - 0.17%
(0.07%) |
||
|
|
|
|
|
|
Option cost
|
|
0.00% - 5.00%
(1.34%) |
||
|
|
|
|
|
|
Risk margin to reflect uncertainty
|
|
0.31% - 0.96%
(0.40%) |
||
|
|
|
|
|
|
Morbidity risk margin
|
|
0.00% - 2.00%
(0.07%) |
||
|
Derivatives:
|
|
|
|
|
|
|
|
||
|
FIA embedded derivatives included in contractholder funds
|
|
|
|
Discounted cash flow
|
|
Market value of option
|
|
0.00% - 26.37%
(1.12%) |
|
|
|
|
|
|
|
SWAP rates
|
|
0.52% - 0.72%
(0.62%) |
||
|
|
|
|
|
|
Mortality multiplier
|
|
80.00% - 80.00%
(80.00%) |
||
|
|
|
|
|
|
Surrender rates
|
|
0.50% - 75.00%
(5.66%) |
||
|
|
|
|
|
|
Partial withdrawals
|
|
2.00% - 3.50%
(2.53%) |
||
|
|
|
|
|
|
Non-performance spread
|
|
0.25% - 0.25%
(0.25%) |
||
|
|
|
|
|
|
Option cost
|
|
0.09% - 16.61%
(2.14%) |
||
|
Preferred shares reimbursement feature embedded derivative
|
|
|
|
Black Derman Toy model
|
|
Credit Spread
|
|
7.51%
|
|
|
|
|
|
|
|
Yield Volatility
|
|
20%
|
||
|
Total financial liabilities at fair value
|
$
|
|
|
|
|
|
|
|
|
|
|
Fair Value at
|
|
Valuation Technique
|
|
Unobservable Input(s)
|
|
Range (Weighted average)
|
||
|
|
December 31, 2019
|
|
|
|
December 31, 2019
|
||||
|
Assets
|
|
|
|
|
|
|
|
||
|
Asset-backed securities
|
$
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
98.65% - 119.35%
(102.02%) |
|
Asset-backed securities
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
0.00% - 99.43%
(35.96%) |
|
|
Commercial mortgage-backed securities
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
100.15% - 127.60%
(126.82%) |
|
|
Corporates
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
83.51% - 106.73%
(99.56%) |
|
|
Corporates
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
98.58% - 119.44%
(105.06%) |
|
|
Hybrids
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
104.72% - 104.72%
(104.72%) |
|
|
Municipals
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
127.68% - 127.68%
(127.68%) |
|
|
Residential mortgage-backed securities
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
0.00% - 106.50%
(106.28%) |
|
|
Foreign governments
|
|
|
|
Third-Party Valuation
|
|
Offered quotes
|
|
110.12% - 118.09%
(112.61%) |
|
|
Equity securities (Salus preferred equity)
|
|
|
|
Income-Approach
|
|
Yield
|
|
2.47%
|
|
|
Other Invested Assets:
|
|
|
|
|
|
|
|
||
|
Available-for-sale embedded derivative (AnchorPath)
|
|
|
|
Black Scholes model
|
|
Market value of AnchorPath fund
|
|
100.00%
|
|
|
Credit Linked Note
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
100.00%
|
|
|
Funds withheld for reinsurance receivables at fair value
|
|
|
|
Broker-quoted
|
|
Offered quotes
|
|
100.00%
|
|
|
Total financial assets at fair value
|
$
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
||
|
Future policy benefits
|
|
|
|
Discounted cash flow
|
|
Market value of option
|
|
0.00% - 11.20% (2.50%)
|
|
|
|
|
|
|
|
Mortality multiplier
|
|
80.00% - 120.00% (95.46%)
|
||
|
|
|
|
|
|
Surrender rates
|
|
0.00% - 55.00% (21.18%)
|
||
|
|
|
|
|
|
Partial withdrawals
|
|
0.00% - 4.00% (2.28%)
|
||
|
|
|
|
|
|
Non-performance spread
|
|
0.00% - 0.08% (0.03%)
|
||
|
|
|
|
|
|
Option cost
|
|
0.00% - 5.02% (1.28%)
|
||
|
|
|
|
|
|
Risk margin to reflect uncertainty
|
|
0.23% - 0.96% (0.34%)
|
||
|
|
|
|
|
|
Morbidity risk margin
|
|
0.00% - 2.00% (0.07%)
|
||
|
Derivatives:
|
|
|
|
|
|
|
|
||
|
FIA embedded derivatives included in contractholder funds
|
|
|
|
Discounted cash flow
|
|
Market value of option
|
|
0.00% - 32.54%
(3.64%) |
|
|
|
|
|
|
|
SWAP rates
|
|
1.73% - 1.90%
(1.81%) |
||
|
|
|
|
|
|
Mortality multiplier
|
|
80.00% - 80.00%
(80.00%) |
||
|
|
|
|
|
|
Surrender rates
|
|
0.50% - 75.00%
(5.64%) |
||
|
|
|
|
|
|
Partial withdrawals
|
|
2.00% - 3.50%
(2.53%) |
||
|
|
|
|
|
|
Non-performance spread
|
|
0.25% - 0.25%
(0.25%) |
||
|
|
|
|
|
|
Option cost
|
|
0.18% - 16.61%
(2.12%) |
||
|
Preferred shares reimbursement feature embedded derivative
|
|
|
|
Black Derman Toy model
|
|
Credit Spread
|
|
|
|
|
|
|
|
|
|
Yield Volatility
|
|
|
||
|
Total financial liabilities at fair value
|
$
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2020
|
|
|
||||||||||||||||||||||||||||||||
|
|
Balance at Beginning
of Period |
|
Total Gains (Losses)
|
|
Purchases
|
|
Sales
|
|
Settlements
|
|
Net transfer In (Out) of
Level 3 (a) |
|
Balance at End of
Period |
|
Change in Unrealized Incl in OCI
|
||||||||||||||||||||
|
|
|
Included in
Earnings |
|
Included in
AOCI |
|
|
|
|
|
|
|||||||||||||||||||||||||
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Fixed maturity securities available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Asset-backed securities
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|||||||||
|
Corporates
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|||||||||
|
Hybrids
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|||||||||
|
Municipals
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|||||||||
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
|||||||||
|
Foreign Governments
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|||||||||
|
Equity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Other invested assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Available-for-sale embedded derivative
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Credit linked note
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Funds withheld for reinsurance receivables, at fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|||||||||
|
Total assets at Level 3 fair value
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
(
|
)
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Future policy benefits
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
FIA embedded derivatives, included in contractholder funds
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Preferred shares reimbursement feature embedded derivative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total liabilities at Level 3 fair value
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Three months ended March 31, 2019
|
||||||||||||||||||||||||||||||
|
|
Balance at Beginning
of Period |
|
Total Gains (Losses)
|
|
Purchases
|
|
Sales
|
|
Settlements
|
|
Net transfer In (Out) of
Level 3 (a) |
|
Balance at End of
Period |
||||||||||||||||||
|
|
|
Included in
Earnings |
|
Included in
AOCI |
|
|
|
|
|
||||||||||||||||||||||
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Fixed maturity securities available-for-sale:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Asset-backed securities
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
Commercial mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||||
|
Corporates
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|
|
|
|
|
||||||||
|
Hybrids
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Municipals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Residential mortgage-backed securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
||||||||
|
Foreign Governments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Equity securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other invested assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Available-for-sale embedded derivative
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Credit linked note
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Funds withheld for reinsurance receivables, at fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
||||||||
|
Total assets at Level 3 fair value
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Future policy benefits (FSRC)
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
FIA embedded derivatives, included in contractholder funds
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Preferred shares reimbursements feature embedded derivative
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Total liabilities at Level 3 fair value
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(
|
)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
March 31, 2020
|
||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total Estimated Fair Value
|
|
Carrying Amount
|
||||||||||
|
Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
|
FHLB common stock
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Commercial mortgage loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Residential mortgage loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Policy loans, included in other invested assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Affiliated other invested assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Company-owned life insurance
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Total
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Investment contracts, included in contractholder funds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
December 31, 2019
|
||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total Estimated Fair Value
|
|
Carrying Amount
|
||||||||||
|
Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
|
FHLB common stock
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Commercial mortgage loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Residential mortgage loans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Policy loans, included in other invested assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Company-owned life insurance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Affiliated other invested assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Funds withheld for reinsurance receivables, at fair value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Liabilities
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Investment contracts, included in contractholder funds
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Total
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Carrying Value After Measurement
|
||||||
|
|
March 31, 2020
|
|
December 31, 2019
|
||||
|
Equity securities
|
$
|
|
|
|
$
|
|
|
|
Limited partnership investment, included in other invested assets
|
|
|
|
|
|
||
|
|
VOBA
|
|
DAC
|
|
DSI
|
|
Total
|
||||||||
|
Balance at December 31, 2019
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Deferrals
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Amortization
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Interest
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Unlocking
|
(
|
)
|
|
(
|
)
|
|
|
|
|
(
|
)
|
||||
|
Adjustment for net unrealized investment (gains) losses
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Balance at March 31, 2020
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
VOBA
|
|
DAC
|
|
DSI
|
|
Total
|
||||||||
|
Balance at December 31, 2018
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Deferrals
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Amortization
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||
|
Interest
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Unlocking
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Adjustment for net unrealized investment (gains) losses
|
(
|
)
|
|
|
|
|
|
|
|
(
|
)
|
||||
|
Balance at March 31, 2019
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
Estimated Amortization Expense
|
|
|
Fiscal Year
|
|
|
|
2020
|
|
|
|
2021
|
|
|
|
2022
|
|
|
|
2023
|
|
|
|
2024
|
|
|
|
Thereafter
|
|
|
|
|
Cost
|
|
Accumulated amortization
|
|
Net carrying amount
|
|
Weighted average useful life (years)
|
||||||
|
Trade marks / trade names
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
State insurance licenses
|
|
|
|
N/A
|
|
|
|
|
|
Indefinite
|
|||
|
Total
|
|
|
|
|
$
|
18
|
|
|
|
||||
|
|
March 31, 2020
|
|
December 31, 2019
|
||||
|
Debt
|
$
|
|
|
|
$
|
|
|
|
Date Declared
|
|
Date Paid
|
|
Date Shareholders of record
|
|
Shareholders of record (in thousands)
|
|
Cash Dividend declared (per share)
|
|
Total cash paid
|
|
February 26, 2020
|
|
March 30, 2020
|
|
March 16, 2020
|
|
|
|
$
|
|
$
|
|
Date Declared
|
|
Date Paid
|
|
Date Shareholders of record
|
|
Shareholders of record (in thousands)
|
|
Cash Dividend declared (per share)
|
|
Total cash paid
|
|
February 27, 2019
|
|
April 1, 2019
|
|
March 18, 2019
|
|
221,661
|
|
$0.01
|
|
$2
|
|
Type of Preferred Share
|
|
Date Declared
|
|
Date Paid
|
|
Date Shareholders of record
|
|
Shares outstanding at date of record (in thousands)
|
|
Method of Payment
|
|
Total cash paid
|
Total shares paid in kind (in thousands)
|
|
Series A Preferred Shares
|
|
March 31, 2020
|
|
April 1, 2020
|
|
March 15, 2020
|
|
|
|
Paid in kind
|
|
$
|
|
|
Series B Preferred Shares
|
|
March 31, 2020
|
|
April 1, 2020
|
|
March 15, 2020
|
|
|
|
Paid in kind
|
|
$
|
|
|
Type of Preferred Share
|
|
Date Declared
|
|
Date Paid
|
|
Date Shareholders of record
|
|
Shares outstanding at date of record (in thousands)
|
|
Method of Payment
|
|
Total cash paid
|
Total shares paid in kind (in thousands)
|
|
Series A Preferred Shares
|
|
March 29, 2019
|
|
April 1, 2019
|
|
March 15, 2019
|
|
|
|
Paid in kind
|
|
$
|
|
|
Series B Preferred Shares
|
|
March 29, 2019
|
|
April 1, 2019
|
|
March 15, 2019
|
|
|
|
Paid in kind
|
|
$
|
|
|
Stock Option Awards
|
Options
|
|
Weighted Average
Exercise Price
|
|||
|
Stock options outstanding at December 31, 2019
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
Exercised
|
|
|
|
|
|
|
|
Forfeited or expired
|
(
|
)
|
|
|
|
|
|
Stock options outstanding at March 31, 2020
|
|
|
|
|
|
|
|
Exercisable at March 31, 2020
|
|
|
|
|
|
|
|
Vested or projected to vest at March 31, 2020
|
|
|
|
|
|
|
|
Restricted Stock Awards
|
|
Shares
|
|
Weighted Average Grant
Date Fair Value
|
|||
|
Restricted shares outstanding at December 31, 2019
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
Vested
|
|
|
|
|
|
|
|
|
Forfeited or expired
|
|
|
|
|
|
|
|
|
Vested or expected to vest at March 31, 2020
|
|
|
|
|
|
|
|
|
Phantom units
|
|
Shares
|
|
Weighted Average Grant
Date Fair Value
|
|||
|
Phantom units outstanding at December 31, 2019
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
Vested
|
|
(
|
)
|
|
|
|
|
|
Forfeited or expired
|
|
|
|
|
|
|
|
|
Phantom units outstanding at March 31, 2020
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||
|
|
March 31, 2020
|
||
|
Total stock compensation expense
|
|
|
|
|
Related tax benefit
|
|
|
|
|
Net stock compensation expense
|
$
|
|
|
|
|
|
Unrecognized Compensation
Expense |
|
Weighted Average Recognition
Period in Years |
||
|
FGL Incentive Plan
|
|
|
|
|
|
|
|
Management Incentive Plan
|
|
|
|
|
|
|
|
Total unrecognized stock compensation expense
|
|
$
|
|
|
|
|
|
|
March 31, 2020
|
||
|
Asset Type
|
|
||
|
Other invested assets
|
$
|
|
|
|
Fixed maturity securities, available-for-sale
|
|
|
|
|
Other assets
|
$
|
|
|
|
Residential mortgage loans
|
|
|
|
|
Total
|
$
|
|
|
|
|
Three months ended
|
||||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
||||||||
|
|
Net Premiums Earned
|
|
Net Benefits Incurred
|
|
Net Premiums Earned
|
|
Net Benefits Incurred
|
||||
|
Direct
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
Ceded
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
Net
|
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
||||
|
Net income (loss)
|
$
|
(
|
)
|
|
$
|
|
|
|
Less Preferred stock dividend
|
|
|
|
|
|
||
|
Net income (loss) available to common shares
|
(
|
)
|
|
|
|
||
|
|
|
|
|
||||
|
Weighted-average common shares outstanding - basic
|
|
|
|
|
|
||
|
Dilutive effect of unvested restricted stock
|
|
|
|
|
|
||
|
Weighted-average shares outstanding - diluted
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Net income (loss) per common share:
|
|
|
|
||||
|
Basic
|
$
|
(
|
)
|
|
$
|
|
|
|
Diluted
|
$
|
(
|
)
|
|
$
|
|
|
|
•
|
general economic conditions and other factors, including prevailing interest and unemployment rate levels and stock and credit market performance;
|
|
•
|
concentration in certain states for distribution of our products;
|
|
•
|
the impact of interest rate fluctuations;
|
|
•
|
equity market volatility;
|
|
•
|
credit market volatility or disruption;
|
|
•
|
the impact of credit risk of our counterparties;
|
|
•
|
volatility or decline in the market price of our ordinary shares could impair our ability to raise necessary capital;
|
|
•
|
changes in our assumptions and estimates regarding the amortization of our deferred acquisition costs, deferred sales inducements and value of business acquired balances;
|
|
•
|
changes in our methodologies, estimates and assumptions regarding our valuation of investments and the determinations of the amounts of allowances and impairments;
|
|
•
|
changes in our valuation allowance against our deferred tax assets, and restrictions on our ability to fully utilize such assets;
|
|
•
|
the accuracy of management’s insurance contract reserving assumptions;
|
|
•
|
regulatory changes or actions, including those relating to regulation of financial services affecting (among other things) underwriting of insurance products and regulation of the sale, underwriting and pricing of products and minimum capitalization and statutory reserve requirements for insurance companies, or the ability of our insurance subsidiaries to make cash distributions to us (including dividends or payments on surplus notes those subsidiaries issue to us);
|
|
•
|
the ability to maintain or obtain approval of Iowa Insurance Division ("IID") and other regulatory authorities as required for our operations and those of our insurance subsidiaries
|
|
•
|
the impact of the "fiduciary" rule proposals on the Company, its products, distribution and business model;
|
|
•
|
changes in the federal income tax laws and regulations which may affect the relative income tax advantages of our products;
|
|
•
|
changes in tax laws which affect us and/or our shareholders;
|
|
•
|
potential adverse tax consequences if we are treated as a passive foreign investment company;
|
|
•
|
the impact on our business of new accounting rules or changes to existing accounting rules;
|
|
•
|
our potential need and our insurance subsidiaries’ potential need for additional capital to maintain our and their financial strength and credit ratings and meet other requirements and obligations;
|
|
•
|
our ability to successfully acquire new companies or businesses and integrate such acquisitions into our existing framework;
|
|
•
|
the impact of potential litigation, including class action litigation;
|
|
•
|
our ability to protect our intellectual property;
|
|
•
|
our ability to maintain effective internal controls over financial reporting;
|
|
•
|
the impact of restrictions in the Company's debt instruments on its ability to operate its business, finance its capital needs or pursue or expand its business strategies;
|
|
•
|
our ability and our insurance subsidiaries’ ability to maintain or improve financial strength ratings;
|
|
•
|
the performance of third parties including third party administrators, independent distributors, underwriters, actuarial consultants and other outsourcing relationships;
|
|
•
|
the loss of key personnel;
|
|
•
|
interruption or other operational failures in telecommunication, information technology and other operational systems, or a failure to maintain the security, integrity, confidentiality or privacy of sensitive data residing on such systems;
|
|
•
|
our exposure to unidentified or unanticipated risk not adequately addressed by our risk management policies and procedures;
|
|
•
|
the impact on our business of natural and man-made catastrophes, pandemics, and malicious and terrorist acts; specifically the pandemic caused by the spread of COVID-19, which could have an adverse impact on our financial condition and results of operations and other aspects of our business;
|
|
•
|
our ability to compete in a highly competitive industry;
|
|
•
|
our ability to attract and retain independent marketing organizations (IMOs) and independent agents;
|
|
•
|
our subsidiaries’ ability to pay dividends to us;
|
|
•
|
the occurrence of any event, change or other circumstances that could give rise to the termination of our merger agreement with Fidelity National Financial, Inc. ("FNF");
|
|
•
|
the outcome of any legal proceedings that may be instituted against us or FNF following the announcement of the merger agreement and the transaction contemplated therein;
|
|
•
|
the inability to complete the transactions contemplated by the merger agreement, including due to failure to obtain approval of our shareholders or other conditions to closing in the merger agreement;
|
|
•
|
delays in obtaining or the inability to obtain necessary regulatory approvals (including approval from insurance regulators) required to complete the transaction contemplated by the merger agreement;
|
|
•
|
the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement or could otherwise cause the transaction contemplated by the merger agreement to fail to close;
|
|
•
|
the risk that the transactions contemplated by the merger agreement disrupt our or FNF's current plans and operations as a result of the announcement thereof;
|
|
•
|
the ability to recognize the anticipated benefits of the transactions contemplated by the merger agreement, which may be affected by, among other things, competition, the ability of our and FNF's management to grow and manage their respective business profitability and to retain their key employees;
|
|
•
|
costs related to the transactions contemplated by the merger agreement;
|
|
•
|
changes in applicable laws or regulations;
|
|
•
|
the risk that the transactions contemplated by the merger agreement will not qualify for their intended tax treatment;
|
|
•
|
adverse legal and regulatory developments or determinations or adverse changes in, or interpretations of, U.S. or other foreign laws, rules or regulations, including tax laws, rules and regulations, that could delay or prevent completion of the transactions contemplated by the merger agreement, cause the terms of such transactions to be modified or changed the anticipated tax consequences of such transactions;
|
|
•
|
the possibility that we or FNF may be adversely affected by other economic, business, and/or competitive factors, as well as the impact on the business, operations, results of operations and trading prices of our and FNF's shares arising out of the COVID-19 outbreak; and
|
|
•
|
the other factors discussed in “Risk Factors” of our
2019
Form 10-K and other risks and uncertainties identified in our and FNF's filings with the SEC.
|
|
|
Annuity Sales
|
|
IUL Sales
|
||||||||||||
|
(dollars in millions)
|
2020
|
|
2019
|
|
2020
|
|
2019
|
||||||||
|
First Quarter
|
$
|
1,045
|
|
|
$
|
1,053
|
|
|
$
|
11
|
|
|
$
|
8
|
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease)
|
||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Premiums
|
$
|
10
|
|
|
$
|
16
|
|
|
$
|
(6
|
)
|
|
Net investment income
|
317
|
|
|
289
|
|
|
28
|
|
|||
|
Net investment gains (losses)
|
(692
|
)
|
|
240
|
|
|
(932
|
)
|
|||
|
Insurance and investment product fees and other
|
30
|
|
|
55
|
|
|
(25
|
)
|
|||
|
Total revenues
|
(335
|
)
|
|
600
|
|
|
(935
|
)
|
|||
|
Benefits and expenses:
|
|
|
|
|
|
||||||
|
Benefits and other changes in policy reserves
|
(41
|
)
|
|
339
|
|
|
(380
|
)
|
|||
|
Acquisition and operating expenses, net of deferrals
|
96
|
|
|
44
|
|
|
52
|
|
|||
|
Amortization of intangibles
|
(61
|
)
|
|
29
|
|
|
(90
|
)
|
|||
|
Total benefits and expenses
|
(6
|
)
|
|
412
|
|
|
(418
|
)
|
|||
|
Operating income (loss)
|
(329
|
)
|
|
188
|
|
|
(517
|
)
|
|||
|
Interest expense
|
(8
|
)
|
|
(8
|
)
|
|
—
|
|
|||
|
Income (loss) before income taxes
|
(337
|
)
|
|
180
|
|
|
(517
|
)
|
|||
|
Income tax (expense) benefit
|
(1
|
)
|
|
(9
|
)
|
|
8
|
|
|||
|
Net income (loss)
|
$
|
(338
|
)
|
|
$
|
171
|
|
|
$
|
(509
|
)
|
|
Less Preferred stock dividend
|
8
|
|
|
8
|
|
|
—
|
|
|||
|
Net income (loss) available to common shareholders
|
$
|
(346
|
)
|
|
$
|
163
|
|
|
$
|
(509
|
)
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Fixed index annuities ("FIA")
|
$
|
831
|
|
|
$
|
668
|
|
|
$
|
163
|
|
|
Fixed rate annuities ("MYGA")
|
114
|
|
|
280
|
|
|
(166
|
)
|
|||
|
Institutional spread based
|
100
|
|
|
105
|
|
|
(5
|
)
|
|||
|
Total annuity
|
$
|
1,045
|
|
|
$
|
1,053
|
|
|
$
|
(8
|
)
|
|
|
|
|
|
|
|
||||||
|
Index universal life ("IUL")
|
$
|
11
|
|
|
$
|
8
|
|
|
$
|
3
|
|
|
|
|
|
|
|
|
||||||
|
Flow reinsurance
|
$
|
122
|
|
|
$
|
60
|
|
|
$
|
62
|
|
|
•
|
FIA sales during the three
months ended
March 31, 2020
compared to
2019
reflect disciplined pricing to achieve profit and capital targets and reflect the Company’s growth strategy.
|
|
•
|
MYGA sales during the three
months ended
March 31, 2020
compared to
2019
were driven by lower interest rates in the current year.
|
|
•
|
Institutional spread based products reflect funding agreements with Federal Home Loan Bank, under an investment strategy that is subject to fluctuation period to period.
|
|
•
|
The increase in flow reinsurance for the
three
months ended
March 31, 2020
compared to
2019
reflects F&G Re's assumed third party flow reinsurance.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Traditional life insurance
|
$
|
6
|
|
|
$
|
8
|
|
|
$
|
(2
|
)
|
|
Life-contingent immediate annuity
|
4
|
|
|
8
|
|
|
(4
|
)
|
|||
|
Premiums
|
$
|
10
|
|
|
$
|
16
|
|
|
$
|
(6
|
)
|
|
•
|
Traditional life insurance premiums for the three months ended March 31, 2020 reflect a decrease compared to March 31, 2019 due to the maturing of the return of premium block of business.
|
|
•
|
Immediate annuity premiums for the
three
months ended
March 31, 2020
reflect a decrease as a result of policyholder behavior for annuitizations as well as FGL Insurance's additional reinsurance agreement with Kubera Insurance (SAC) Ltd. ("Kubera"), effective June 30, 2019.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease)
|
||||||
|
Fixed maturity securities, available-for-sale
|
$
|
258
|
|
|
$
|
265
|
|
|
$
|
(7
|
)
|
|
Equity securities
|
14
|
|
|
21
|
|
|
(7
|
)
|
|||
|
Mortgage loans
|
21
|
|
|
7
|
|
|
14
|
|
|||
|
Invested cash and short-term investments
|
4
|
|
|
3
|
|
|
1
|
|
|||
|
Funds withheld
|
22
|
|
|
8
|
|
|
14
|
|
|||
|
Limited partnerships
|
25
|
|
|
8
|
|
|
17
|
|
|||
|
Other investments
|
6
|
|
|
5
|
|
|
1
|
|
|||
|
Gross investment income
|
350
|
|
|
317
|
|
|
33
|
|
|||
|
Investment expense
|
(33
|
)
|
|
(28
|
)
|
|
(5
|
)
|
|||
|
Net investment income
|
$
|
317
|
|
|
$
|
289
|
|
|
$
|
28
|
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Yield on AAUM (at amortized cost)
|
4.38
|
%
|
|
4.47
|
%
|
|
(0.09
|
)%
|
|||
|
Less: Interest credited and option cost
|
(2.14
|
)%
|
|
(2.30
|
)%
|
|
0.16
|
%
|
|||
|
Net investment spread
|
2.24
|
%
|
|
2.17
|
%
|
|
0.07
|
%
|
|||
|
AAUM
|
$
|
28,924
|
|
|
$
|
25,862
|
|
|
$
|
3,062
|
|
|
•
|
The increase in AAUM from
March 31, 2019
to
March 31, 2020
is primarily the result of
$2.4 billion
net new business asset flows and an offshore
$0.9 billion
assumed third-party block reinsurance transaction in April 2019, partially offset by
$0.2 billion
reinsurance cession to Kubera in June 2019.
|
|
•
|
The
10%
increase in NII from the three months ended
March 31, 2019
to the three months ended
March 31, 2020
was primarily as a result of invested asset growth and net portfolio reposition uplift, partially offset by lower floating rate income and higher planned investment expense.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Net realized and unrealized gains (losses) on fixed maturity available-for-sale securities, equity securities and other invested assets
|
$
|
(121
|
)
|
|
$
|
76
|
|
|
$
|
(197
|
)
|
|
Change in allowance for expected credit losses
|
(48
|
)
|
|
—
|
|
|
(48
|
)
|
|||
|
Net realized and unrealized gains (losses) on certain derivatives instruments
|
(358
|
)
|
|
164
|
|
|
(522
|
)
|
|||
|
Change in fair value of reinsurance related embedded derivatives
|
(161
|
)
|
|
(3
|
)
|
|
(158
|
)
|
|||
|
Change in fair value of other derivatives and embedded derivatives
|
(4
|
)
|
|
3
|
|
|
(7
|
)
|
|||
|
Net investment gains (losses)
|
$
|
(692
|
)
|
|
$
|
240
|
|
|
$
|
(932
|
)
|
|
•
|
For the three months ended
March 31, 2020
, net realized and unrealized gains (losses) on available-for-sale securities, equity securities and other invested assets includes
$(135)
in unrealized gains (losses) on equity securities due to a change in fair value arising from market volatility. The three months ended March 31, 2019 includes
$86
in unrealized gains (losses) on equity securities due to a change in fair value arising from market volatility and
$2
of credit related impairments.
|
|
•
|
The three months ended
March 31, 2020
reflect
$(48)
loss due to the change in allowance for expected credit losses as a result of the adoption of ASU 2016-13 on January 1, 2020.
|
|
•
|
For the three months ended
March 31, 2020
, the net realized and unrealized gains (losses) on certain derivative instruments primarily relates to the realized and unrealized losses on futures and options used to hedge FIA and IUL products, primarily due to the change in underlying indices as well as timing of option and future purchases and expirations.
|
|
•
|
The fair value of reinsurance related embedded derivative is based on the change in fair value of the underlying assets held in the funds withheld ("FWH") portfolio.
|
|
•
|
See the table below for primary drivers of gains (losses) on certain derivatives.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Call Options:
|
|
|
|
|
|
||||||
|
Gains (losses) on option expiration
|
$
|
33
|
|
|
$
|
(33
|
)
|
|
$
|
66
|
|
|
Change in unrealized gains (losses)
|
(393
|
)
|
|
188
|
|
|
(581
|
)
|
|||
|
Futures contracts:
|
|
|
|
|
|
||||||
|
Gains (losses) on futures contracts expiration
|
3
|
|
|
7
|
|
|
(4
|
)
|
|||
|
Change in unrealized gains (losses)
|
(3
|
)
|
|
2
|
|
|
(5
|
)
|
|||
|
Foreign currency forward:
|
|
|
|
|
|
||||||
|
Gains (losses) on foreign currency forward
|
2
|
|
|
2
|
|
|
—
|
|
|||
|
Total net change in fair value
|
$
|
(358
|
)
|
|
$
|
166
|
|
|
$
|
(524
|
)
|
|
|
|
|
|
|
|
||||||
|
Annual Point-to-Point Change in S&P 500 Index during the period
|
(9
|
)%
|
|
9
|
%
|
|
(18
|
)%
|
|||
|
•
|
Realized gains and losses on certain derivative instruments are directly correlated to the performance of the indices upon which the call options and futures contracts are based and the value of the derivatives at the time of expiration compared to the value at the time of purchase. Gains (losses) on option expiration reflect the movement during the
three
months ended
March 31, 2020
and
2019
on options settled during the respective period.
|
|
•
|
Additionally, the change in unrealized gains and losses due to fair value of call options are primarily driven by the underlying performance of the S&P 500 Index during each respective year relative to the S&P Index on the policyholder buy dates.
|
|
•
|
The net change in fair value of the call options and futures contracts for the three
months ended
March 31, 2020
and
2019
was primarily driven by movements in the S&P 500 Index relative to the policyholder buy dates.
|
|
|
Three months ended
|
|
|
|||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
|||
|
Average Crediting Rate
|
3
|
%
|
|
1
|
%
|
|
2
|
%
|
|
S&P 500 Index:
|
|
|
|
|
|
|||
|
Point-to-point strategy
|
3
|
%
|
|
2
|
%
|
|
1
|
%
|
|
Monthly average strategy
|
3
|
%
|
|
1
|
%
|
|
2
|
%
|
|
Monthly point-to-point strategy
|
3
|
%
|
|
—
|
%
|
|
3
|
%
|
|
3 year high water mark
|
13
|
%
|
|
17
|
%
|
|
(4
|
)%
|
|
•
|
Actual amounts credited to contractholder fund balances may differ from the index appreciation due to contractual features in the FIA contracts (caps, spreads and participation rates) which allow the Company to manage the cost of the options purchased to fund the annual index credits. Market volatility compared to previous years can impact index credits differently than overall S&P 500 Index fluctuation.
|
|
•
|
The credits for the
three
months ended
March 31, 2020
and
2019
were based on comparing the S&P 500 Index on each issue date in these respective periods to the same issue date in the respective prior year periods. Due to volatility in the S&P 500 Index, policyholders with anniversaries during the
three
months ended
March 31, 2020
, on average, received more credits as compared to the
three
months ended
March 31, 2019
.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Surrender charges
|
$
|
6
|
|
|
$
|
8
|
|
|
$
|
(2
|
)
|
|
Cost of insurance fees and other income
|
24
|
|
|
47
|
|
|
(23
|
)
|
|||
|
Total insurance and investment product fees and other
|
$
|
30
|
|
|
$
|
55
|
|
|
$
|
(25
|
)
|
|
•
|
Surrender charges were higher in the prior year period, primarily due to a higher number of universal life policy surrenders.
|
|
•
|
Cost of insurance fees and other income were higher in the prior year period due to the amortization of the deferred reinsurance gain established at the amendment of FGL Insurance's reinsurance agreement with Kubera at June 30, 2019, as well as net unearned revenue liability impacts.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
FIA embedded derivative impact
|
(101
|
)
|
|
152
|
|
|
(253
|
)
|
|||
|
Index credits, interest credited & bonuses
|
148
|
|
|
91
|
|
|
57
|
|
|||
|
Annuity payments
|
31
|
|
|
34
|
|
|
(3
|
)
|
|||
|
Change in fair value of reserve liabilities held at fair value
|
(115
|
)
|
|
68
|
|
|
(183
|
)
|
|||
|
Other policy benefits and reserve movements
|
(4
|
)
|
|
(6
|
)
|
|
2
|
|
|||
|
Total benefits and other changes in policy reserves
|
$
|
(41
|
)
|
|
$
|
339
|
|
|
$
|
(380
|
)
|
|
•
|
The FIA fair value option liability increased quarter over quarter, driven by the changes in the equity markets and risk free rates during the respective periods. The change in risk free rates increased the FIA embedded derivative liability by approximately
$273
during the three months ended
March 31, 2020
as compared to a decrease of
$58
for the corresponding period in
2019
, with an offsetting
$369
decrease and additional
$117
increase, respectively, from changes in the equity markets. The change in equity market also impacts the fair value of the derivative assets hedging our FIA policies. See table in the net investment gains/losses discussion above for summary and discussion of net unrealized gains (losses) on certain derivative instruments.
|
|
•
|
The quarter over quarter increases in index credits, interest credited & bonuses were primarily due to higher index credits on FIA policies, reflecting market movement during the respective periods.
|
|
•
|
The change in the fair value of reserve liabilities held at fair value decreased for the three months ended
March 31, 2020
primarily due to market movement during the period.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
General expenses
|
$
|
73
|
|
|
$
|
31
|
|
|
$
|
42
|
|
|
Acquisition and operating expenses
|
128
|
|
|
103
|
|
|
25
|
|
|||
|
Deferred acquisition costs
|
(105
|
)
|
|
(90
|
)
|
|
(15
|
)
|
|||
|
Total acquisition and operating expenses, net of deferrals
|
$
|
96
|
|
|
$
|
44
|
|
|
$
|
52
|
|
|
•
|
The increase in acquisition and operating expenses, net of deferrals, during the three months ended
March 31, 2020
compared to the prior year three months ended
March 31, 2019
is primarily due to an increase in the preferred equity remarketing reimbursement embedded derivative liability and increased project costs.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Amortization
|
$
|
(56
|
)
|
|
$
|
36
|
|
|
$
|
(92
|
)
|
|
Interest
|
(10
|
)
|
|
(7
|
)
|
|
(3
|
)
|
|||
|
Unlocking
|
5
|
|
|
—
|
|
|
5
|
|
|||
|
Total amortization of intangibles
|
$
|
(61
|
)
|
|
$
|
29
|
|
|
$
|
(90
|
)
|
|
•
|
Amortization of intangibles is based on historical, current and future expected gross margins (pre-tax operating income before amortization). The change in amortization year over year is the result of actual gross profits ("AGPs") in each period on the DAC and VOBA lines of business ("LOBs"). The decrease in amortization quarter over quarter was driven primarily by net realized and unrealized investment losses in the current period.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Income before taxes
|
$
|
(337
|
)
|
|
$
|
180
|
|
|
$
|
(517
|
)
|
|
|
|
|
|
|
|
||||||
|
Income tax before valuation allowance
|
(41
|
)
|
|
30
|
|
|
(71
|
)
|
|||
|
Change in valuation allowance
|
42
|
|
|
(21
|
)
|
|
63
|
|
|||
|
Income tax expense (benefit)
|
$
|
1
|
|
|
$
|
9
|
|
|
$
|
(8
|
)
|
|
Effective rate
|
—
|
%
|
|
5
|
%
|
|
(5
|
)%
|
|||
|
•
|
Income tax expense for the three months ended
March 31, 2020
was
$1
, inclusive of a valuation allowance expense of
$42
, compared to income tax expense of
$9
for the three months ended
March 31, 2019
, net of a valuation allowance release of
$21
. The decrease in income tax expense of $8 quarter over quarter is primarily due to the decrease in pre-tax income, largely offset by the valuation allowance expense recorded on FSRC's deferred tax assets for the three months ended
March 31, 2020
.
|
|
|
Three months ended
|
|
|
||||||||
|
|
March 31, 2020
|
|
March 31, 2019
|
|
Increase/
(Decrease) |
||||||
|
Net income (loss)
|
$
|
(338
|
)
|
|
$
|
171
|
|
|
$
|
(509
|
)
|
|
Adjustments to arrive at AOI:
|
|
|
|
|
|
||||||
|
Effect of investment losses (gains), net of offsets (a)
|
133
|
|
|
(70
|
)
|
|
203
|
|
|||
|
Impacts related to changes in the fair values of FIA related derivatives and embedded derivatives, net of hedging cost, and the fair value accounting impacts of assumed reinsurance by our international subsidiaries (a)
|
287
|
|
|
(17
|
)
|
|
304
|
|
|||
|
Effect of change in fair value of reinsurance related embedded derivative, net of offsets (a)
|
(39
|
)
|
|
19
|
|
|
(58
|
)
|
|||
|
Effects of integration, merger related & other non-operating items
|
34
|
|
|
(3
|
)
|
|
37
|
|
|||
|
Tax impact of adjusting items
|
(36
|
)
|
|
(10
|
)
|
|
(26
|
)
|
|||
|
AOI
|
$
|
41
|
|
|
$
|
90
|
|
|
$
|
(49
|
)
|
|
Less Preferred stock dividend
|
$
|
8
|
|
|
$
|
8
|
|
|
$
|
—
|
|
|
AOI available to common shareholders
|
$
|
33
|
|
|
$
|
82
|
|
|
$
|
(49
|
)
|
|
•
|
AOI for the three months ended
March 31, 2020
included the following unfavorable notable items:
$(21)
expense related to the tax valuation allowance established against FSRC’s deferred tax assets,
$(5)
net unfavorable actual to expected mortality within the single premium immediate annuity (“SPIA”) product line and other reserve adjustments,
$(4)
nondeferred commissions expense adjustment, and
$(2)
project costs. Comparatively, the three months ended
March 31, 2019
AOI included the following net favorable notable items:
$14
net favorable actual to expected mortality within the SPIA product line and other reserve movements and
$5
bond prepay income and other, partially offset by
$2
project costs. Adjusting for notable items in both periods, AOI was in line with the prior year quarter.
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||
|
|
Fair Value
|
|
Percent
|
|
Fair Value
|
|
Percent
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
Fixed maturity securities, available for sale:
|
|
|
|
|
|
|
|
||||||
|
United States Government full faith and credit
|
$
|
43
|
|
|
—
|
%
|
|
$
|
34
|
|
|
—
|
%
|
|
United States Government sponsored entities
|
124
|
|
|
—
|
%
|
|
134
|
|
|
—
|
%
|
||
|
United States municipalities, states and territories
|
1,318
|
|
|
5
|
%
|
|
1,343
|
|
|
5
|
%
|
||
|
Foreign Governments
|
141
|
|
|
1
|
%
|
|
155
|
|
|
1
|
%
|
||
|
Corporate securities:
|
|
|
|
|
|
|
|
|
|||||
|
Finance, insurance and real estate
|
4,032
|
|
|
16
|
%
|
|
4,234
|
|
|
15
|
%
|
||
|
Manufacturing, construction and mining
|
684
|
|
|
3
|
%
|
|
771
|
|
|
3
|
%
|
||
|
Utilities, energy and related sectors
|
2,049
|
|
|
8
|
%
|
|
2,452
|
|
|
9
|
%
|
||
|
Wholesale/retail trade
|
1,432
|
|
|
6
|
%
|
|
1,617
|
|
|
6
|
%
|
||
|
Services, media and other
|
2,254
|
|
|
9
|
%
|
|
2,523
|
|
|
9
|
%
|
||
|
Hybrid securities
|
891
|
|
|
3
|
%
|
|
1,027
|
|
|
4
|
%
|
||
|
Non-agency residential mortgage-backed securities
|
746
|
|
|
3
|
%
|
|
820
|
|
|
3
|
%
|
||
|
Commercial mortgage-backed securities
|
2,481
|
|
|
10
|
%
|
|
2,922
|
|
|
10
|
%
|
||
|
Asset-backed securities
|
4,945
|
|
|
19
|
%
|
|
5,694
|
|
|
20
|
%
|
||
|
Total fixed maturity available for sale securities
|
21,140
|
|
|
83
|
%
|
|
23,726
|
|
|
85
|
%
|
||
|
Equity securities (a)
|
915
|
|
|
4
|
%
|
|
1,071
|
|
|
4
|
%
|
||
|
Commercial mortgage loans
|
507
|
|
|
2
|
%
|
|
435
|
|
|
1
|
%
|
||
|
Residential mortgage loans
|
1,297
|
|
|
5
|
%
|
|
848
|
|
|
3
|
%
|
||
|
Other (primarily derivatives and limited partnerships)
|
1,667
|
|
|
6
|
%
|
|
1,875
|
|
|
7
|
%
|
||
|
Total investments
|
$
|
25,526
|
|
|
100
|
%
|
|
$
|
27,955
|
|
|
100
|
%
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||
|
Rating
|
Fair Value
|
|
Percent
|
|
Fair Value
|
|
Percent
|
||||||
|
AAA
|
$
|
519
|
|
|
2
|
%
|
|
$
|
496
|
|
|
2
|
%
|
|
AA
|
1,430
|
|
|
7
|
%
|
|
1,520
|
|
|
6
|
%
|
||
|
A
|
6,153
|
|
|
29
|
%
|
|
6,601
|
|
|
28
|
%
|
||
|
BBB
|
7,331
|
|
|
35
|
%
|
|
8,800
|
|
|
37
|
%
|
||
|
Not rated (c)
|
4,019
|
|
|
19
|
%
|
|
4,304
|
|
|
18
|
%
|
||
|
Total investment grade
|
19,452
|
|
|
92
|
%
|
|
21,721
|
|
|
91
|
%
|
||
|
BB (a)
|
1,156
|
|
|
6
|
%
|
|
1,353
|
|
|
6
|
%
|
||
|
B and below (b)
|
431
|
|
|
2
|
%
|
|
519
|
|
|
2
|
%
|
||
|
Not rated (c)
|
101
|
|
|
—
|
%
|
|
133
|
|
|
1
|
%
|
||
|
Total below investment grade
|
1,688
|
|
|
8
|
%
|
|
2,005
|
|
|
9
|
%
|
||
|
Total
|
$
|
21,140
|
|
|
100
|
%
|
|
$
|
23,726
|
|
|
100
|
%
|
|
NAIC Designation
|
|
NRSRO Equivalent Rating
|
|
1
|
|
AAA/AA/A
|
|
2
|
|
BBB
|
|
3
|
|
BB
|
|
4
|
|
B
|
|
5
|
|
CCC and lower
|
|
6
|
|
In or near default
|
|
|
|
March 31, 2020
|
|||||||||
|
NAIC Designation
|
|
Amortized Cost
|
|
Fair Value
|
|
Percent of Total Fair Value
|
|||||
|
1
|
|
$
|
12,248
|
|
|
$
|
11,704
|
|
|
56
|
%
|
|
2
|
|
8,947
|
|
|
8,198
|
|
|
39
|
%
|
||
|
3
|
|
1,207
|
|
|
881
|
|
|
4
|
%
|
||
|
4
|
|
335
|
|
|
283
|
|
|
1
|
%
|
||
|
5
|
|
99
|
|
|
74
|
|
|
—
|
%
|
||
|
6
|
|
—
|
|
|
—
|
|
|
—
|
%
|
||
|
Total
|
|
$
|
22,836
|
|
|
$
|
21,140
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|||||
|
|
|
December 31, 2019
|
|||||||||
|
NAIC Designation
|
|
Amortized Cost
|
|
Fair Value
|
|
Percent of Total Fair Value
|
|||||
|
1
|
|
$
|
12,326
|
|
|
$
|
12,829
|
|
|
54
|
%
|
|
2
|
|
9,046
|
|
|
9,350
|
|
|
39
|
%
|
||
|
3
|
|
1,112
|
|
|
1,108
|
|
|
5
|
%
|
||
|
4
|
|
273
|
|
|
280
|
|
|
1
|
%
|
||
|
5
|
|
157
|
|
|
159
|
|
|
1
|
%
|
||
|
6
|
|
—
|
|
|
—
|
|
|
—
|
%
|
||
|
Total
|
|
$
|
22,914
|
|
|
$
|
23,726
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|||||
|
|
|
March 31, 2020
|
|||||
|
Top 10 Industry Concentration
|
|
Fair Value
|
|
Percent of Total Fair Value
|
|||
|
ABS collateralized loan obligation ("CLO")
|
|
$
|
3,416
|
|
|
15
|
%
|
|
Banking
|
|
2,216
|
|
|
10
|
%
|
|
|
Whole loan collateralized mortgage obligation ("CMO")
|
|
2,122
|
|
|
10
|
%
|
|
|
Life insurance
|
|
1,526
|
|
|
7
|
%
|
|
|
ABS Other
|
|
1,499
|
|
|
7
|
%
|
|
|
Municipal
|
|
1,318
|
|
|
6
|
%
|
|
|
Electric
|
|
1,190
|
|
|
5
|
%
|
|
|
CMBS
|
|
743
|
|
|
3
|
%
|
|
|
Technology
|
|
670
|
|
|
3
|
%
|
|
|
Healthcare
|
|
527
|
|
|
2
|
%
|
|
|
Total
|
|
$
|
15,227
|
|
|
69
|
%
|
|
|
|
December 31, 2019
|
|||||
|
Top 10 Industry Concentration
|
|
Fair Value
|
|
Percent of Total Fair Value
|
|||
|
ABS collateralized loan obligation ("CLO")
|
|
$
|
3,881
|
|
|
16
|
%
|
|
Whole loan collateralized mortgage obligation ("CMO")
|
|
2,479
|
|
|
10
|
%
|
|
|
Banking
|
|
2,414
|
|
|
10
|
%
|
|
|
ABS Other
|
|
1,779
|
|
|
7
|
%
|
|
|
Life insurance
|
|
1,610
|
|
|
6
|
%
|
|
|
Municipal
|
|
1,343
|
|
|
5
|
%
|
|
|
Electric
|
|
1,261
|
|
|
5
|
%
|
|
|
CMBS
|
|
887
|
|
|
4
|
%
|
|
|
Technology
|
|
694
|
|
|
3
|
%
|
|
|
Pipelines
|
|
648
|
|
|
3
|
%
|
|
|
Total
|
|
$
|
16,996
|
|
|
68
|
%
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||||
|
|
Amortized Cost
|
|
Fair Value
|
|
Amortized Cost
|
|
Fair Value
|
||||||||
|
Corporate, Non-structured Hybrids, Municipal and Government securities:
|
|
|
|
|
|
|
|
||||||||
|
Due in one year or less
|
$
|
84
|
|
|
$
|
80
|
|
|
$
|
85
|
|
|
$
|
85
|
|
|
Due after one year through five years
|
915
|
|
|
870
|
|
|
888
|
|
|
914
|
|
||||
|
Due after five years through ten years
|
1,942
|
|
|
1,872
|
|
|
2,020
|
|
|
2,082
|
|
||||
|
Due after ten years
|
10,378
|
|
|
10,022
|
|
|
10,496
|
|
|
11,075
|
|
||||
|
Subtotal
|
$
|
13,319
|
|
|
$
|
12,844
|
|
|
$
|
13,489
|
|
|
$
|
14,156
|
|
|
Other securities which provide for periodic payments:
|
|
|
|
|
|
|
|
||||||||
|
Asset-backed securities
|
$
|
5,785
|
|
|
$
|
4,945
|
|
|
$
|
5,720
|
|
|
$
|
5,694
|
|
|
Commercial-mortgage-backed securities
|
2,848
|
|
|
2,481
|
|
|
2,788
|
|
|
2,922
|
|
||||
|
Residential mortgage-backed securities
|
884
|
|
|
870
|
|
|
917
|
|
|
954
|
|
||||
|
Subtotal
|
$
|
9,517
|
|
|
$
|
8,296
|
|
|
$
|
9,425
|
|
|
$
|
9,570
|
|
|
Total fixed maturity available-for-sale securities
|
$
|
22,836
|
|
|
$
|
21,140
|
|
|
$
|
22,914
|
|
|
$
|
23,726
|
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||
|
NAIC Designation:
|
Fair Value
|
|
Percent of Total
|
|
Fair Value
|
|
Percent of Total
|
||||||
|
1
|
$
|
165
|
|
|
91
|
%
|
|
$
|
193
|
|
|
92
|
%
|
|
2
|
6
|
|
|
3
|
%
|
|
6
|
|
|
3
|
%
|
||
|
3
|
1
|
|
|
1
|
%
|
|
1
|
|
|
—
|
%
|
||
|
4
|
9
|
|
|
5
|
%
|
|
11
|
|
|
5
|
%
|
||
|
5
|
—
|
|
|
—
|
%
|
|
—
|
|
|
—
|
%
|
||
|
6
|
—
|
|
|
—
|
%
|
|
—
|
|
|
—
|
%
|
||
|
Total
|
$
|
181
|
|
|
100
|
%
|
|
$
|
211
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
||||||
|
NRSRO:
|
|
|
|
|
|
|
|
||||||
|
AAA
|
$
|
—
|
|
|
—
|
%
|
|
$
|
1
|
|
|
—
|
%
|
|
AA
|
6
|
|
|
3
|
%
|
|
7
|
|
|
3
|
%
|
||
|
A
|
20
|
|
|
11
|
%
|
|
21
|
|
|
10
|
%
|
||
|
BBB
|
11
|
|
|
6
|
%
|
|
5
|
|
|
2
|
%
|
||
|
Not rated - Above investment grade (a)
|
33
|
|
|
18
|
%
|
|
34
|
|
|
16
|
%
|
||
|
BB and below
|
111
|
|
|
62
|
%
|
|
143
|
|
|
69
|
%
|
||
|
Total
|
$
|
181
|
|
|
100
|
%
|
|
$
|
211
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
||||||
|
Vintage:
|
|
|
|
|
|
|
|
||||||
|
2017
|
$
|
13
|
|
|
7
|
%
|
|
$
|
13
|
|
|
6
|
%
|
|
2007
|
37
|
|
|
20
|
%
|
|
44
|
|
|
21
|
%
|
||
|
2006
|
45
|
|
|
25
|
%
|
|
55
|
|
|
26
|
%
|
||
|
2005 and prior
|
86
|
|
|
48
|
%
|
|
99
|
|
|
47
|
%
|
||
|
Total
|
$
|
181
|
|
|
100
|
%
|
|
$
|
211
|
|
|
100
|
%
|
|
|
March 31, 2020
|
|
December 31, 2019
|
||||||||||
|
Asset Class
|
Fair Value
|
|
Percent
|
|
Fair Value
|
|
Percent
|
||||||
|
ABS CLO
|
$
|
3,416
|
|
|
69
|
%
|
|
$
|
3,881
|
|
|
68
|
%
|
|
ABS auto
|
30
|
|
|
1
|
%
|
|
34
|
|
|
1
|
%
|
||
|
ABS other
|
1,499
|
|
|
30
|
%
|
|
1,779
|
|
|
31
|
%
|
||
|
Total ABS
|
$
|
4,945
|
|
|
100
|
%
|
|
$
|
5,694
|
|
|
100
|
%
|
|
|
March 31, 2020
|
|||||||||||||||||
|
|
Number of securities
|
|
Amortized Cost
|
|
Allowance for Expected Credit Losses
|
|
Unrealized Losses
|
|
Fair Value
|
|||||||||
|
Fixed maturity securities, available for sale:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
United States Government sponsored agencies
|
21
|
|
|
61
|
|
|
—
|
|
|
(7
|
)
|
|
54
|
|
||||
|
United States municipalities, states and territories
|
30
|
|
|
388
|
|
|
—
|
|
|
(14
|
)
|
|
374
|
|
||||
|
Foreign Governments
|
6
|
|
|
34
|
|
|
—
|
|
|
(1
|
)
|
|
33
|
|
||||
|
Corporate securities:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Finance, insurance and real estate
|
135
|
|
|
1,562
|
|
|
—
|
|
|
(103
|
)
|
|
1,459
|
|
||||
|
Manufacturing, construction and mining
|
68
|
|
|
553
|
|
|
(1
|
)
|
|
(61
|
)
|
|
491
|
|
||||
|
Utilities, energy and related sectors
|
156
|
|
|
1,598
|
|
|
(4
|
)
|
|
(306
|
)
|
|
1,288
|
|
||||
|
Wholesale/retail trade
|
108
|
|
|
1,086
|
|
|
(3
|
)
|
|
(163
|
)
|
|
920
|
|
||||
|
Services, media and other
|
119
|
|
|
947
|
|
|
(1
|
)
|
|
(159
|
)
|
|
787
|
|
||||
|
Hybrid securities
|
55
|
|
|
791
|
|
|
—
|
|
|
(91
|
)
|
|
700
|
|
||||
|
Non-agency residential mortgage backed securities
|
132
|
|
|
243
|
|
|
(5
|
)
|
|
(18
|
)
|
|
220
|
|
||||
|
Commercial mortgage backed securities
|
279
|
|
|
2,472
|
|
|
—
|
|
|
(383
|
)
|
|
2,089
|
|
||||
|
Asset backed securities
|
617
|
|
|
5,210
|
|
|
(17
|
)
|
|
(849
|
)
|
|
4,344
|
|
||||
|
Total fixed maturity available for sale securities
|
1,726
|
|
|
14,945
|
|
|
(31
|
)
|
|
(2,155
|
)
|
|
12,759
|
|
||||
|
Equity securities
|
68
|
|
|
985
|
|
|
—
|
|
|
(138
|
)
|
|
847
|
|
||||
|
Total investments
|
1,794
|
|
|
$
|
15,930
|
|
|
$
|
(31
|
)
|
|
$
|
(2,293
|
)
|
|
$
|
13,606
|
|
|
|
December 31, 2019
|
|||||||||||||
|
|
Number of securities
|
|
Amortized Cost
|
|
Unrealized Losses
|
|
Fair Value
|
|||||||
|
Fixed maturity securities, available for sale:
|
|
|
|
|
|
|
|
|||||||
|
United States Government full faith and credit
|
2
|
|
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
6
|
|
|
United States Government sponsored agencies
|
33
|
|
|
36
|
|
|
—
|
|
|
36
|
|
|||
|
United States municipalities, states and territories
|
23
|
|
|
188
|
|
|
(5
|
)
|
|
183
|
|
|||
|
Foreign Governments
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Corporate securities:
|
|
|
|
|
|
|
|
|||||||
|
Finance, insurance and real estate
|
41
|
|
|
413
|
|
|
(14
|
)
|
|
399
|
|
|||
|
Manufacturing, construction and mining
|
20
|
|
|
132
|
|
|
(2
|
)
|
|
130
|
|
|||
|
Utilities, energy and related sectors
|
54
|
|
|
502
|
|
|
(30
|
)
|
|
472
|
|
|||
|
Wholesale/retail trade
|
45
|
|
|
508
|
|
|
(19
|
)
|
|
489
|
|
|||
|
Services, media and other
|
39
|
|
|
351
|
|
|
(7
|
)
|
|
344
|
|
|||
|
Hybrid securities
|
10
|
|
|
87
|
|
|
(4
|
)
|
|
83
|
|
|||
|
Non-agency residential mortgage backed securities
|
62
|
|
|
115
|
|
|
(3
|
)
|
|
112
|
|
|||
|
Commercial mortgage backed securities
|
43
|
|
|
254
|
|
|
(6
|
)
|
|
248
|
|
|||
|
Asset backed securities
|
364
|
|
|
3,249
|
|
|
(77
|
)
|
|
3,172
|
|
|||
|
Total fixed maturity available for sale securities
|
736
|
|
|
5,841
|
|
|
(167
|
)
|
|
5,674
|
|
|||
|
Equity securities
|
33
|
|
|
505
|
|
|
(17
|
)
|
|
488
|
|
|||
|
Total investments
|
769
|
|
|
$
|
6,346
|
|
|
$
|
(184
|
)
|
|
$
|
6,162
|
|
|
|
March 31, 2020
|
|||||||||||||||||
|
|
Number of securities
|
|
Amortized Cost
|
|
Fair Value
|
|
Allowance for Expected Credit Loss
|
|
Gross Unrealized Losses
|
|||||||||
|
Investment grade:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Less than six months
|
95
|
|
|
$
|
1,430
|
|
|
$
|
1,192
|
|
|
$
|
—
|
|
|
$
|
(238
|
)
|
|
Six months or more and less than twelve months
|
4
|
|
|
29
|
|
|
24
|
|
|
—
|
|
|
(5
|
)
|
||||
|
Twelve months or greater
|
10
|
|
|
107
|
|
|
68
|
|
|
—
|
|
|
(39
|
)
|
||||
|
Total investment grade
|
109
|
|
|
1,566
|
|
|
1,284
|
|
|
—
|
|
|
(282
|
)
|
||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Below investment grade:
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Less than six months
|
43
|
|
|
362
|
|
|
241
|
|
|
(7
|
)
|
|
(114
|
)
|
||||
|
Six months or more and less than twelve months
|
5
|
|
|
67
|
|
|
27
|
|
|
—
|
|
|
(40
|
)
|
||||
|
Twelve months or greater
|
29
|
|
|
253
|
|
|
134
|
|
|
(14
|
)
|
|
(105
|
)
|
||||
|
Total below investment grade
|
77
|
|
|
682
|
|
|
402
|
|
|
(21
|
)
|
|
(259
|
)
|
||||
|
Total
|
186
|
|
|
$
|
2,248
|
|
|
$
|
1,686
|
|
|
$
|
(21
|
)
|
|
$
|
(541
|
)
|
|
|
December 31, 2019
|
|||||||||||||
|
|
Number of securities
|
|
Amortized Cost
|
|
Fair Value
|
|
Gross Unrealized Losses
|
|||||||
|
Investment grade:
|
|
|
|
|
|
|
|
|||||||
|
Less than six months
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Six months or more and less than twelve months
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Twelve months or greater
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Total investment grade
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
|
|
|
|
|
|
|
|
|||||||
|
Below investment grade:
|
|
|
|
|
|
|
|
|||||||
|
Less than six months
|
1
|
|
|
3
|
|
|
2
|
|
|
(1
|
)
|
|||
|
Six months or more and less than twelve months
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
|
Twelve months or greater
|
3
|
|
|
42
|
|
|
33
|
|
|
(9
|
)
|
|||
|
Total below investment grade
|
4
|
|
|
45
|
|
|
35
|
|
|
(10
|
)
|
|||
|
Total
|
5
|
|
|
$
|
45
|
|
|
$
|
35
|
|
|
$
|
(10
|
)
|
|
(dollars in millions)
|
Three months ended
|
||||||
|
|
March 31,
2020 |
|
March 31,
2019 |
||||
|
Cash provided by (used in):
|
|
|
|
||||
|
Operating activities
|
$
|
(265
|
)
|
|
$
|
96
|
|
|
Investing activities
|
(521
|
)
|
|
404
|
|
||
|
Financing activities
|
593
|
|
|
286
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
$
|
(193
|
)
|
|
$
|
786
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
|
(Dollars in millions)
|
|
|
|
|||
|
Duration (years)
|
Amortized Cost
|
|
|
% of Total
|
||
|
0-4
|
$
|
12,049
|
|
|
44
|
%
|
|
5-9
|
6,535
|
|
|
24
|
%
|
|
|
10-14
|
6,225
|
|
|
23
|
%
|
|
|
15-19
|
2,307
|
|
|
9
|
%
|
|
|
20-25
|
68
|
|
|
—
|
%
|
|
|
Total
|
$
|
27,184
|
|
|
100
|
%
|
|
(Dollars in millions)
|
|
|
|
Financial Strength Rating
|
||||||
|
Parent Company/Principal Reinsurers
|
|
Reinsurance Recoverable
|
|
AM Best
|
|
S&P
|
|
Fitch
|
|
Moody's
|
|
Wilton Re
|
|
$1,507
|
|
A+
|
|
Not Rated
|
|
A+
|
|
Not Rated
|
|
Kubera Insurance (SAC) Ltd
|
|
835
|
|
Not Rated
|
|
Not Rated
|
|
Not Rated
|
|
Not Rated
|
|
Security Life of Denver
|
|
155
|
|
Not Rated
|
|
A+
|
|
A
|
|
A3
|
|
Hannover Re
|
|
130
|
|
A+
|
|
AA-
|
|
Not Rated
|
|
Not Rated
|
|
London Life
|
|
106
|
|
A+
|
|
Not Rated
|
|
Not Rated
|
|
Not Rated
|
|
Item 4.
|
Controls and Procedures
|
|
Exhibit
No.
|
|
Description of Exhibits
|
|
31.1 *
|
|
|
|
31.2 *
|
|
|
|
32.1 *
|
|
|
|
32.2 *
|
|
|
|
101 *
|
|
The following financial information from FGL Holdings' Quarterly Report on Form 10-Q for the period ended March 31, 2020 is formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets as of March 31, 2020 (unaudited) and December 31, 2019, (ii) the Condensed Consolidated Statements of Operations (unaudited), (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited), (iv) the Condensed Consolidated Statements of Changes in Stockholders Equity (unaudited), (v) the Condensed Consolidated Statements of Cash Flows (unaudited), and (vi) Notes to the Condensed Consolidated Financial Statements.
|
|
104 *
|
|
The cover page from FGL Holdings' Quarterly Report on Form 10-Q for the period ended March 31, 2020 is formatted in Inline XBRL (Extensible Business Reporting Language).
|
|
*
|
Filed herewith
|
|
|
|
FGL HOLDINGS (Registrant)
|
|
|
|
|
|
|
|
Date:
|
May 6, 2020
|
By:
|
/s/ John Fleurant
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
(on behalf of the Registrant and as Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|